Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 176   

Articles published

GSK 1,476.21 -0.79 (-0.05%)
price chart
My Top 3 Pharmaceutical Stocks For 2015: GlaxoSmithKline plc, AstraZeneca ...
Investing in BTG, AstraZeneca and GlaxoSmithKline could prove to be a great move for 2015, and I think that all three companies could post excellent returns over the next year.
GlaxoSmithKline plc Stock Rating Reaffirmed by JPMorgan Chase & Co. (GSK)
GlaxoSmithKline plc (ADR) logo JPMorgan Chase & Co. restated their neutral rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a report issued on Tuesday. JPMorgan Chase & Co. has also taken action a number of other healthcare stocks recently.
GlaxoSmithKline plc Receives Underperform Rating from Credit Suisse (GSK)  Watch List News (press release)
Related articles »  
Why Forecasts Are Falling At GlaxoSmithKline plc
The company's quarterly figures this year have been falling short of expectations too, and at the first-half stage Glaxo reported a 12% fall in core EPS at constant exchange rates, with the statutory reported figure down 14% - at real exchange rates ...
GlaxoSmithKline plc Jumps After Beating City Expectations
Glaxo remains under investigation by regulators within in both the UK and US. But still, the conclusion of this investigation has removed much uncertainty surrounding the group's future, uncertainty which has dragged on Glaxo's share price. The company ...
GlaxoSmithKline plc Shares Up After Earnings  ValueWalk
Glaxo Pledges to Cut Costs After Earnings Beat Estimates  Businessweek
Related articles »  
AstraZeneca plc And GlaxoSmithKline plc Are Strong Buys, But For Very ...
Astra couldn't have risen faster, its share price up 40% in the last year. Glaxo couldn't have been more slow, its share price down almost 15% in a year.
JPMorgan Chase & Co. Reiterates �Neutral� Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc logo JPMorgan Chase & Co. reissued their neutral rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report released on Tuesday morning.
GlaxoSmithKline plc Earns "Add" Rating from AlphaValue (GSK)
Shares of GlaxoSmithKline plc (LON:GSK) traded up 0.41% during mid-day trading on Thursday, hitting GBX 1477.00. The stock had a trading volume of 7,839,790 shares.
GlaxoSmithKline plc Given �Underperform� Rating at Credit Suisse (GSK)
GlaxoSmithKline plc (ADR) logo Credit Suisse reiterated their underperform rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research note released on Wednesday morning.
Why Have GlaxoSmithKline plc And AstraZeneca plc Followed The FTSE 100 ...
Investors tend to turn to big blue-chip dividend payers at times of market volatility, and in times past the steady earnings of pharma giants GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) have been a particular source of comfort when the market ...
Related articles »  
5 Things GlaxoSmithKline plc Stock's Management Wants You to Know
British pharma giant GlaxoSmithKline (NYSE: GSK ) is at the epicenter of the industrywide crisis known as the patent cliff.
Related articles »